We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most lymphomas and gliomas showed moderate cytoplasmic immunoreactivity which also was observed on occasion in other cancer tissues. The remaining cancer tissues were mainly negative.
A majority of cancer cells showed weak to moderate cytoplasmic staining combined with cases of nuclear positivity. Most renal cancers and a few cases of liver cancers displayed strong immunoreactivity. Several cases of testicular and skin cancers were negative.
CTIF is a component of the CBP80 (NCBP1; MIM 600469)/CBP20 (NCBP2; MIM 605133) translation initiation complex that binds cotranscriptionally to the cap end of nascent mRNA. The CBP80/CBP20 complex is involved in a simultaneous editing and translation step that recognizes premature termination codons (PTCs) in mRNAs and directs PTC-containing mRNAs toward nonsense-mediated decay (NMD). On mRNAs without PTCs, the CBP80/CBP20 complex is replaced with cytoplasmic mRNA cap-binding proteins, including EIF4G (MIM 600495), and steady-state translation of the mRNAs resumes in the cytoplasm (Kim et al., 2009 [PubMed 19648179]).[supplied by OMIM, Dec 2009]